Homology Medicines
Stock Forecast, Prediction & Price Target
Homology Medicines Financial Estimates
Homology Medicines Revenue Estimates
Homology Medicines EBITDA Estimates
Homology Medicines Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | |
Revenue
% change YoY
| $33.97M N/A | $3.20M -90.55% | $1.15M -63.96% | Avg: $2M Low: $2M High: $2M avg. 73.01% | Avg: $2M Low: $2M High: $2M avg. 0% | Avg: $2M Low: $2M High: $2M avg. 0% | |
Net Income
% change YoY
| $-95.57M N/A | $483K 100.50% | $-112.96M -23487.37% | Avg: $-40.5M Low: $-224.91K High: $-224.91K avg. 64.14% | Avg: $-37.5M Low: $-208.84K High: $-208.84K avg. 7.40% | Avg: $-311.66K Low: $-311.66K High: $-311.66K avg. 99.16% | |
EBITDA
% change YoY
| $-87.59M N/A | $-263.23M -200.51% | $-91.52M 65.23% | Avg: $-2M Low: $-2M High: $-2M avg. 97.81% | Avg: $-2M Low: $-2M High: $-2M avg. 0% | Avg: $-2M Low: $-2M High: $-2M avg. 0% | |
EPS
% change YoY
| -$311.2 N/A | $1.51 100.48% | -$351.57 -23382.78% | Avg: -$0.7 Low: -$0.7 High: -$0.7 avg. 99.80% | Avg: -$0.65 Low: -$0.65 High: -$0.65 avg. 7.14% | Avg: -$0.97 Low: -$0.97 High: -$0.97 avg. -49.23% | |
Operating Expenses
% change YoY
| $129.92M N/A | $136.48M 5.05% | $92.68M -32.09% | Avg: $25.95M Low: $25.95M High: $25.95M avg. -71.99% | Avg: $25.95M Low: $25.95M High: $25.95M avg. 0% | Avg: $25.95M Low: $25.95M High: $25.95M avg. 0% | |
FAQ
What is Homology Medicines stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 56.90% in 2025-2027.
We have gathered data from 1 analysts. Their low estimate is -224.91K, average is -40.5M and high is -224.91K.
What is Homology Medicines stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 24.33% in 2025-2027.
We have gathered data from 1 analysts. Their low revenue estimate is $2M, average is $2M and high is $2M.
What is Homology Medicines stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 19.23% in 2025-2027.
We have gathered data from 1 analysts. Their low earnings per share estimate is -$0.7, average is -$0.7 and high is $-0.7.
What is the best performing analyst?
In the last twelve months analysts have been covering Homology Medicines stock. The most successful analyst is Patrick Trucchio.